Merit Medical Systems furnished historical revenue data disaggregated by new Foundational and Therapeutic product categories for fiscal years 2022-2025 and quarterly periods from Q1 2024 to Q4 2025.
Key takeaways
Total revenue increased from $1.15 billion in 2022 to $1.52 billion in 2025 under the new reporting structure.
Foundational product revenue grew to $1.03 billion in 2025, representing the larger of the two main categories.
Therapeutic product revenue rose to $487.4 million in 2025, up from $288.6 million in 2022.
Q4 2025 total revenue was $393.9 million, compared to $355.2 million in the corresponding 2024 period.
The company stated this historical information does not constitute a revision or restatement of previous financials.